Partnering with Labs and Clinics
In the United States, Techcyte is for research use only. In the EU the Techcyte Platform is CE marked under the Directive 98/79/EC on in vitro diagnostics medical devices (IVDD). Usage in other countries is dependent upon ar country’s regulations. Please, contact us if you have any questions.
Techcyte Proves the Value of Digital Diagnostics
In the May issue of the Journal of Clinical Microbiology, Vol. 58, Issue #6, described a validation of Techcyte’s process for detecting protozoa in trichrome-stained fecal smears. The study describes using Techcyte’s AI-based digital diagnostic tools to review and screenout parasite-free smears, which would allow parasitologists to focus on confirming and characterizing protozoa that are detected—saving valuable time and effort.
This is not a pilot study, but a full validation of Techcyte’s solution, which includes accuracy, precision, and limit of detection analysis.
In the same issue, Daniel Rhoads, MD., Department of Pathology, Case Western Reserve University, wrote an editorial opinion on the study, which includes additional insights.
“Computer vision represents the next frontier in laboratory diagnostics. Computer vision in the year 2020 is analogous to PCR in the year 2000. AI in general and computer vision in specific are emerging diagnostic tools for clinical microbiology.”
“Deep learning image analysis tools, that assist the lab professional and pathologist in diagnosing disease, present a real opportunity to make a significant impact on accuracy, efficiency and costs.”
Department of Laboratory Medicine and Pathology, Division of Hematopathology
Techcyte was created using the most advanced AI and internet technologies available.
It continuously improves, is always up-to-date and is securely available
over the web on desktop and mobile devices.
Interested in a live demonstration? Do you have a question that we can answer? Please, feel free to contact us. We would appreciate the opportunity to let you know a little more about Techcyte.